Literature DB >> 23136203

Suppression of vaccine immunity by inflammatory monocytes.

Leah A Mitchell1, Angela J Henderson, Steven W Dow.   

Abstract

Vaccine adjuvant-induced inflammation augments vaccine immunity in part by recruiting APCs to vaccine draining lymph nodes (LNs). However, the role of one APC subtype, inflammatory monocytes, in regulating vaccine immunity in healthy animals has not been fully examined in detail. Therefore, vaccine-mediated monocyte recruitment and subsequent immune responses were investigated using murine vaccination models and in vitro assays. Recruitment of inflammatory monocytes to vaccine draining LNs was rapid and mediated primarily by local production of MCP-1, as revealed by studies in MCP-1(-/-) mice. Interrupting monocyte recruitment to LNs by either transient monocyte depletion or monocyte migration blockade led to marked amplification of both cellular and humoral immune responses to vaccination. These results were most consistent with the idea that rapidly mobilized inflammatory monocytes were actually suppressing vaccine responses. The suppressive nature of vaccine-elicited monocytes was confirmed using in vitro cocultures of murine monocytes and T cells. Furthermore, it was determined that inflammatory monocytes suppressed T cell responses by sequestering cysteine, as cysteine supplementation in vitro and in vivo appreciably augmented vaccine responses. These findings indicated, therefore, that vaccination-elicited inflammation, although necessary for effective immunity, also generated potent counter-regulatory immune responses that were mediated primarily by inflammatory monocytes. Therefore, interrupting monocyte-mediated vaccine counterregulatory responses may serve as an effective new strategy for broadly amplifying vaccine immunity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23136203      PMCID: PMC3527633          DOI: 10.4049/jimmunol.1202151

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  Ammonium pyrrolidine dithiocarbamate and RS 102895 attenuate opioid withdrawal in vivo and in vitro.

Authors:  Ashish K Rehni; Nirmal Singh
Journal:  Psychopharmacology (Berl)       Date:  2011-09-20       Impact factor: 4.530

2.  Molecular mechanisms involving sigma receptor-mediated induction of MCP-1: implication for increased monocyte transmigration.

Authors:  Honghong Yao; Yanjing Yang; Kee Jun Kim; Crystal Bethel-Brown; Nan Gong; Keiko Funa; Howard E Gendelman; Tsung-Ping Su; John Q Wang; Shilpa Buch
Journal:  Blood       Date:  2010-03-30       Impact factor: 22.113

3.  Chemotherapy rescues tumor-driven aberrant CD4+ T-cell differentiation and restores an activated polyfunctional helper phenotype.

Authors:  Zhi-Chun Ding; Bruce R Blazar; Andrew L Mellor; David H Munn; Gang Zhou
Journal:  Blood       Date:  2010-01-29       Impact factor: 22.113

4.  IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2/monocyte chemoattractant protein-1 induction.

Authors:  Shiva Shahrara; Sarah R Pickens; Arthur M Mandelin; William J Karpus; Qiquan Huang; Jay K Kolls; Richard M Pope
Journal:  J Immunol       Date:  2010-03-12       Impact factor: 5.422

5.  Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice.

Authors:  Melisa J Hamilton; Judit P Banáth; Vivian Lam; Nancy E Lepard; Gerald Krystal; Kevin L Bennewith
Journal:  Cancer Immunol Immunother       Date:  2011-10-22       Impact factor: 6.968

6.  CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.

Authors:  Bin-Zhi Qian; Jiufeng Li; Hui Zhang; Takanori Kitamura; Jinghang Zhang; Liam R Campion; Elizabeth A Kaiser; Linda A Snyder; Jeffrey W Pollard
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

Review 7.  Transforming growth factor beta (TGF-beta) and inflammation in cancer.

Authors:  Brian Bierie; Harold L Moses
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-16       Impact factor: 7.638

8.  Mycobacterium bovis bacillus Calmette-Guérin vaccination mobilizes innate myeloid-derived suppressor cells restraining in vivo T cell priming via IL-1R-dependent nitric oxide production.

Authors:  Angelo Martino; Edgar Badell; Valérie Abadie; Viviane Balloy; Michel Chignard; Michel-Yves Mistou; Béhazine Combadière; Christophe Combadière; Nathalie Winter
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

9.  Critical protective role for MCP-1 in pneumonic Burkholderia mallei infection.

Authors:  Andrew Goodyear; Abby Jones; Ryan Troyer; Helle Bielefeldt-Ohmann; Steven Dow
Journal:  J Immunol       Date:  2009-12-30       Impact factor: 5.422

10.  CCR2 acts as scavenger for CCL2 during monocyte chemotaxis.

Authors:  Silvia Volpe; Elisabetta Cameroni; Barbara Moepps; Sylvia Thelen; Tiziana Apuzzo; Marcus Thelen
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

View more
  23 in total

Review 1.  Monocyte differentiation and antigen-presenting functions.

Authors:  Claudia V Jakubzick; Gwendalyn J Randolph; Peter M Henson
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

2.  The Angiotensin Receptor Blocker Losartan Suppresses Growth of Pulmonary Metastases via AT1R-Independent Inhibition of CCR2 Signaling and Monocyte Recruitment.

Authors:  Daniel P Regan; Jonathan W Coy; Kirti Kandhwal Chahal; Lyndah Chow; Jade N Kurihara; Amanda M Guth; Irina Kufareva; Steven W Dow
Journal:  J Immunol       Date:  2019-04-10       Impact factor: 5.422

3.  The Suppressive Attitude of Inflammatory Monocytes in Antiviral Antibody Responses.

Authors:  Eleonora Sala; Mirela Kuka
Journal:  Viral Immunol       Date:  2020-02-06       Impact factor: 2.257

4.  Immunosuppressive myeloid cells induced by chemotherapy attenuate antitumor CD4+ T-cell responses through the PD-1-PD-L1 axis.

Authors:  Zhi-Chun Ding; Xiaoyun Lu; Miao Yu; Henrique Lemos; Lei Huang; Phillip Chandler; Kebin Liu; Matthew Walters; Antoni Krasinski; Matthias Mack; Bruce R Blazar; Andrew L Mellor; David H Munn; Gang Zhou
Journal:  Cancer Res       Date:  2014-04-29       Impact factor: 12.701

5.  Defective TGF-β signaling in bone marrow-derived cells prevents hedgehog-induced skin tumors.

Authors:  Qipeng Fan; Dongsheng Gu; Hailan Liu; Ling Yang; Xiaoli Zhang; Mervin C Yoder; Mark H Kaplan; Jingwu Xie
Journal:  Cancer Res       Date:  2013-11-26       Impact factor: 12.701

6.  Optimized dosing of a CCR2 antagonist for amplification of vaccine immunity.

Authors:  Leah A Mitchell; Ryan J Hansen; Adam J Beaupre; Daniel L Gustafson; Steven W Dow
Journal:  Int Immunopharmacol       Date:  2012-12-13       Impact factor: 4.932

7.  Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.

Authors:  Ediane B Silva; Andrew Goodyear; Marjorie D Sutherland; Nicole L Podnecky; Mercedes Gonzalez-Juarrero; Herbert P Schweizer; Steven W Dow
Journal:  Infect Immun       Date:  2013-10-07       Impact factor: 3.441

Review 8.  Viral subversion of B cell responses within secondary lymphoid organs.

Authors:  Mirela Kuka; Matteo Iannacone
Journal:  Nat Rev Immunol       Date:  2017-12-18       Impact factor: 53.106

9.  A novel cancer immunotherapy utilizing autologous tumour tissue.

Authors:  Haemin Park; Matthew Gladstone; Crystal Shanley; Raymond Goodrich; Amanda Guth
Journal:  Vox Sang       Date:  2020-05-06       Impact factor: 2.144

10.  Circulating inflammatory monocytes contribute to impaired influenza vaccine responses in HIV-infected participants.

Authors:  Varghese K George; Suresh Pallikkuth; Rajendra Pahwa; Lesley R de Armas; Stefano Rinaldi; Li Pan; Savita Pahwa
Journal:  AIDS       Date:  2018-06-19       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.